世界の静菌性抗生物質市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bacteriostatic Antibiotics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5609
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、静菌性抗生物質の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（テトラサイクリン、ドキシサイクリン、クロラムフェニコール、エリスロマイシン、フシド酸、スルホンアミド、トリメトプリム、マクロライド、リンコサミド、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・静菌性抗生物質の市場動向
・企業の競争状況、市場シェア
・静菌性抗生物質の種類別市場規模と予測2016-2027（テトラサイクリン、ドキシサイクリン、クロラムフェニコール、エリスロマイシン、フシド酸、スルホンアミド、トリメトプリム、マクロライド、リンコサミド、その他）
・静菌性抗生物質の用途別市場規模と予測2016-2027（病院、診療所、その他）
・静菌性抗生物質の北米市場規模2016-2027（アメリカ、カナダ）
・静菌性抗生物質の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・静菌性抗生物質のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・静菌性抗生物質の中南米市場規模2016-2027（メキシコ、ブラジル）
・静菌性抗生物質の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Tetraphase Pharmaceuticals、Allergan、Pfizer、Mylan、Sun Pharmaceutical Industries、Hikma Pharmaceuticals、Akorn、Merck、Guanhao Biotech、Lianhuan Pharmaceutical Group、Layn）
・結論

Bacteriostatic antibiotics limit the growth of bacteria by interfering with bacterial protein production, DNA replication, or other aspects of bacterial cellular metabolism.

Market Analysis and Insights: Global Bacteriostatic Antibiotics Market
The global Bacteriostatic Antibiotics market size is projected to reach US$ 56710 million by 2027, from US$ 47370 million in 2020, at a CAGR of 2.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bacteriostatic Antibiotics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bacteriostatic Antibiotics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bacteriostatic Antibiotics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bacteriostatic Antibiotics market.

Global Bacteriostatic Antibiotics Scope and Market Size
Bacteriostatic Antibiotics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bacteriostatic Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tetracycline
Doxycycline
Chloramphenicol
Erythromycin
Fusidic acid
Sulfonamides
Trimethoprim
Macrolides
Lincosamides
Other

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Tetraphase Pharmaceuticals
Allergan
Pfizer
Mylan
Sun Pharmaceutical Industries
Hikma Pharmaceuticals
Akorn
Merck
Guanhao Biotech
Lianhuan Pharmaceutical Group
Layn

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacteriostatic Antibiotics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tetracycline
1.2.3 Doxycycline
1.2.4 Chloramphenicol
1.2.5 Erythromycin
1.2.6 Fusidic acid
1.2.7 Sulfonamides
1.2.8 Trimethoprim
1.2.9 Macrolides
1.2.10 Lincosamides
1.2.11 Other
1.3 Market by Application
1.3.1 Global Bacteriostatic Antibiotics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bacteriostatic Antibiotics Market Perspective (2016-2027)
2.2 Bacteriostatic Antibiotics Growth Trends by Regions
2.2.1 Bacteriostatic Antibiotics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bacteriostatic Antibiotics Historic Market Share by Regions (2016-2021)
2.2.3 Bacteriostatic Antibiotics Forecasted Market Size by Regions (2022-2027)
2.3 Bacteriostatic Antibiotics Industry Dynamic
2.3.1 Bacteriostatic Antibiotics Market Trends
2.3.2 Bacteriostatic Antibiotics Market Drivers
2.3.3 Bacteriostatic Antibiotics Market Challenges
2.3.4 Bacteriostatic Antibiotics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bacteriostatic Antibiotics Players by Revenue
3.1.1 Global Top Bacteriostatic Antibiotics Players by Revenue (2016-2021)
3.1.2 Global Bacteriostatic Antibiotics Revenue Market Share by Players (2016-2021)
3.2 Global Bacteriostatic Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bacteriostatic Antibiotics Revenue
3.4 Global Bacteriostatic Antibiotics Market Concentration Ratio
3.4.1 Global Bacteriostatic Antibiotics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacteriostatic Antibiotics Revenue in 2020
3.5 Bacteriostatic Antibiotics Key Players Head office and Area Served
3.6 Key Players Bacteriostatic Antibiotics Product Solution and Service
3.7 Date of Enter into Bacteriostatic Antibiotics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bacteriostatic Antibiotics Breakdown Data by Type
4.1 Global Bacteriostatic Antibiotics Historic Market Size by Type (2016-2021)
4.2 Global Bacteriostatic Antibiotics Forecasted Market Size by Type (2022-2027)

5 Bacteriostatic Antibiotics Breakdown Data by Application
5.1 Global Bacteriostatic Antibiotics Historic Market Size by Application (2016-2021)
5.2 Global Bacteriostatic Antibiotics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bacteriostatic Antibiotics Market Size (2016-2027)
6.2 North America Bacteriostatic Antibiotics Market Size by Type
6.2.1 North America Bacteriostatic Antibiotics Market Size by Type (2016-2021)
6.2.2 North America Bacteriostatic Antibiotics Market Size by Type (2022-2027)
6.2.3 North America Bacteriostatic Antibiotics Market Size by Type (2016-2027)
6.3 North America Bacteriostatic Antibiotics Market Size by Application
6.3.1 North America Bacteriostatic Antibiotics Market Size by Application (2016-2021)
6.3.2 North America Bacteriostatic Antibiotics Market Size by Application (2022-2027)
6.3.3 North America Bacteriostatic Antibiotics Market Size by Application (2016-2027)
6.4 North America Bacteriostatic Antibiotics Market Size by Country
6.4.1 North America Bacteriostatic Antibiotics Market Size by Country (2016-2021)
6.4.2 North America Bacteriostatic Antibiotics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Bacteriostatic Antibiotics Market Size (2016-2027)
7.2 Europe Bacteriostatic Antibiotics Market Size by Type
7.2.1 Europe Bacteriostatic Antibiotics Market Size by Type (2016-2021)
7.2.2 Europe Bacteriostatic Antibiotics Market Size by Type (2022-2027)
7.2.3 Europe Bacteriostatic Antibiotics Market Size by Type (2016-2027)
7.3 Europe Bacteriostatic Antibiotics Market Size by Application
7.3.1 Europe Bacteriostatic Antibiotics Market Size by Application (2016-2021)
7.3.2 Europe Bacteriostatic Antibiotics Market Size by Application (2022-2027)
7.3.3 Europe Bacteriostatic Antibiotics Market Size by Application (2016-2027)
7.4 Europe Bacteriostatic Antibiotics Market Size by Country
7.4.1 Europe Bacteriostatic Antibiotics Market Size by Country (2016-2021)
7.4.2 Europe Bacteriostatic Antibiotics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bacteriostatic Antibiotics Market Size (2016-2027)
8.2 Asia-Pacific Bacteriostatic Antibiotics Market Size by Type
8.2.1 Asia-Pacific Bacteriostatic Antibiotics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bacteriostatic Antibiotics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bacteriostatic Antibiotics Market Size by Type (2016-2027)
8.3 Asia-Pacific Bacteriostatic Antibiotics Market Size by Application
8.3.1 Asia-Pacific Bacteriostatic Antibiotics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bacteriostatic Antibiotics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bacteriostatic Antibiotics Market Size by Application (2016-2027)
8.4 Asia-Pacific Bacteriostatic Antibiotics Market Size by Region
8.4.1 Asia-Pacific Bacteriostatic Antibiotics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bacteriostatic Antibiotics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bacteriostatic Antibiotics Market Size (2016-2027)
9.2 Latin America Bacteriostatic Antibiotics Market Size by Type
9.2.1 Latin America Bacteriostatic Antibiotics Market Size by Type (2016-2021)
9.2.2 Latin America Bacteriostatic Antibiotics Market Size by Type (2022-2027)
9.2.3 Latin America Bacteriostatic Antibiotics Market Size by Type (2016-2027)
9.3 Latin America Bacteriostatic Antibiotics Market Size by Application
9.3.1 Latin America Bacteriostatic Antibiotics Market Size by Application (2016-2021)
9.3.2 Latin America Bacteriostatic Antibiotics Market Size by Application (2022-2027)
9.3.3 Latin America Bacteriostatic Antibiotics Market Size by Application (2016-2027)
9.4 Latin America Bacteriostatic Antibiotics Market Size by Country
9.4.1 Latin America Bacteriostatic Antibiotics Market Size by Country (2016-2021)
9.4.2 Latin America Bacteriostatic Antibiotics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bacteriostatic Antibiotics Market Size (2016-2027)
10.2 Middle East & Africa Bacteriostatic Antibiotics Market Size by Type
10.2.1 Middle East & Africa Bacteriostatic Antibiotics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bacteriostatic Antibiotics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bacteriostatic Antibiotics Market Size by Type (2016-2027)
10.3 Middle East & Africa Bacteriostatic Antibiotics Market Size by Application
10.3.1 Middle East & Africa Bacteriostatic Antibiotics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bacteriostatic Antibiotics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bacteriostatic Antibiotics Market Size by Application (2016-2027)
10.4 Middle East & Africa Bacteriostatic Antibiotics Market Size by Country
10.4.1 Middle East & Africa Bacteriostatic Antibiotics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bacteriostatic Antibiotics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Tetraphase Pharmaceuticals
11.1.1 Tetraphase Pharmaceuticals Company Details
11.1.2 Tetraphase Pharmaceuticals Business Overview
11.1.3 Tetraphase Pharmaceuticals Bacteriostatic Antibiotics Introduction
11.1.4 Tetraphase Pharmaceuticals Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.1.5 Tetraphase Pharmaceuticals Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Bacteriostatic Antibiotics Introduction
11.2.4 Allergan Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Bacteriostatic Antibiotics Introduction
11.3.4 Pfizer Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Bacteriostatic Antibiotics Introduction
11.4.4 Mylan Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Company Details
11.5.2 Sun Pharmaceutical Industries Business Overview
11.5.3 Sun Pharmaceutical Industries Bacteriostatic Antibiotics Introduction
11.5.4 Sun Pharmaceutical Industries Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.5.5 Sun Pharmaceutical Industries Recent Development
11.6 Hikma Pharmaceuticals
11.6.1 Hikma Pharmaceuticals Company Details
11.6.2 Hikma Pharmaceuticals Business Overview
11.6.3 Hikma Pharmaceuticals Bacteriostatic Antibiotics Introduction
11.6.4 Hikma Pharmaceuticals Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.6.5 Hikma Pharmaceuticals Recent Development
11.7 Akorn
11.7.1 Akorn Company Details
11.7.2 Akorn Business Overview
11.7.3 Akorn Bacteriostatic Antibiotics Introduction
11.7.4 Akorn Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.7.5 Akorn Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Bacteriostatic Antibiotics Introduction
11.8.4 Merck Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Guanhao Biotech
11.9.1 Guanhao Biotech Company Details
11.9.2 Guanhao Biotech Business Overview
11.9.3 Guanhao Biotech Bacteriostatic Antibiotics Introduction
11.9.4 Guanhao Biotech Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.9.5 Guanhao Biotech Recent Development
11.10 Lianhuan Pharmaceutical Group
11.10.1 Lianhuan Pharmaceutical Group Company Details
11.10.2 Lianhuan Pharmaceutical Group Business Overview
11.10.3 Lianhuan Pharmaceutical Group Bacteriostatic Antibiotics Introduction
11.10.4 Lianhuan Pharmaceutical Group Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.10.5 Lianhuan Pharmaceutical Group Recent Development
11.11 Layn
11.11.1 Layn Company Details
11.11.2 Layn Business Overview
11.11.3 Layn Bacteriostatic Antibiotics Introduction
11.11.4 Layn Revenue in Bacteriostatic Antibiotics Business (2016-2021)
11.11.5 Layn Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bacteriostatic Antibiotics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tetracycline
Table 3. Key Players of Doxycycline
Table 4. Key Players of Chloramphenicol
Table 5. Key Players of Erythromycin
Table 6. Key Players of Fusidic acid
Table 7. Key Players of Sulfonamides
Table 8. Key Players of Trimethoprim
Table 9. Key Players of Macrolides
Table 10. Key Players of Lincosamides
Table 11. Key Players of Other
Table 12. Global Bacteriostatic Antibiotics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Bacteriostatic Antibiotics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 14. Global Bacteriostatic Antibiotics Market Size by Regions (2016-2021) & (US$ Million)
Table 15. Global Bacteriostatic Antibiotics Market Share by Regions (2016-2021)
Table 16. Global Bacteriostatic Antibiotics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 17. Global Bacteriostatic Antibiotics Market Share by Regions (2022-2027)
Table 18. Bacteriostatic Antibiotics Market Trends
Table 19. Bacteriostatic Antibiotics Market Drivers
Table 20. Bacteriostatic Antibiotics Market Challenges
Table 21. Bacteriostatic Antibiotics Market Restraints
Table 22. Global Bacteriostatic Antibiotics Revenue by Players (2016-2021) & (US$ Million)
Table 23. Global Bacteriostatic Antibiotics Market Share by Players (2016-2021)
Table 24. Global Top Bacteriostatic Antibiotics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacteriostatic Antibiotics as of 2020)
Table 25. Ranking of Global Top Bacteriostatic Antibiotics Companies by Revenue (US$ Million) in 2020
Table 26. Global 5 Largest Players Market Share by Bacteriostatic Antibiotics Revenue (CR5 and HHI) & (2016-2021)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Bacteriostatic Antibiotics Product Solution and Service
Table 29. Date of Enter into Bacteriostatic Antibiotics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Bacteriostatic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 32. Global Bacteriostatic Antibiotics Revenue Market Share by Type (2016-2021)
Table 33. Global Bacteriostatic Antibiotics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 34. Global Bacteriostatic Antibiotics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 35. Global Bacteriostatic Antibiotics Market Size Share by Application (2016-2021) & (US$ Million)
Table 36. Global Bacteriostatic Antibiotics Revenue Market Share by Application (2016-2021)
Table 37. Global Bacteriostatic Antibiotics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 38. Global Bacteriostatic Antibiotics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 39. North America Bacteriostatic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 40. North America Bacteriostatic Antibiotics Market Size by Type (2022-2027) & (US$ Million)
Table 41. North America Bacteriostatic Antibiotics Market Size by Application (2016-2021) (US$ Million)
Table 42. North America Bacteriostatic Antibiotics Market Size by Application (2022-2027) & (US$ Million)
Table 43. North America Bacteriostatic Antibiotics Market Size by Country (2016-2021) & (US$ Million)
Table 44. North America Bacteriostatic Antibiotics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Europe Bacteriostatic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 46. Europe Bacteriostatic Antibiotics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Europe Bacteriostatic Antibiotics Market Size by Application (2016-2021) (US$ Million)
Table 48. Europe Bacteriostatic Antibiotics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Europe Bacteriostatic Antibiotics Market Size by Country (2016-2021) & (US$ Million)
Table 50. Europe Bacteriostatic Antibiotics Market Size by Country (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Bacteriostatic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 52. Asia-Pacific Bacteriostatic Antibiotics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Bacteriostatic Antibiotics Market Size by Application (2016-2021) (US$ Million)
Table 54. Asia-Pacific Bacteriostatic Antibiotics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Asia-Pacific Bacteriostatic Antibiotics Market Size by Region (2016-2021) & (US$ Million)
Table 56. Asia-Pacific Bacteriostatic Antibiotics Market Size by Region (2022-2027) & (US$ Million)
Table 57. Latin America Bacteriostatic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 58. Latin America Bacteriostatic Antibiotics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Latin America Bacteriostatic Antibiotics Market Size by Application (2016-2021) (US$ Million)
Table 60. Latin America Bacteriostatic Antibiotics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Latin America Bacteriostatic Antibiotics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Latin America Bacteriostatic Antibiotics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Bacteriostatic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 64. Middle East & Africa Bacteriostatic Antibiotics Market Size by Type (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Bacteriostatic Antibiotics Market Size by Application (2016-2021) (US$ Million)
Table 66. Middle East & Africa Bacteriostatic Antibiotics Market Size by Application (2022-2027) & (US$ Million)
Table 67. Middle East & Africa Bacteriostatic Antibiotics Market Size by Country (2016-2021) & (US$ Million)
Table 68. Middle East & Africa Bacteriostatic Antibiotics Market Size by Country (2022-2027) & (US$ Million)
Table 69. Tetraphase Pharmaceuticals Company Details
Table 70. Tetraphase Pharmaceuticals Business Overview
Table 71. Tetraphase Pharmaceuticals Bacteriostatic Antibiotics Product
Table 72. Tetraphase Pharmaceuticals Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 73. Tetraphase Pharmaceuticals Recent Development
Table 74. Allergan Company Details
Table 75. Allergan Business Overview
Table 76. Allergan Bacteriostatic Antibiotics Product
Table 77. Allergan Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 78. Allergan Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Bacteriostatic Antibiotics Product
Table 82. Pfizer Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Mylan Company Details
Table 85. Mylan Business Overview
Table 86. Mylan Bacteriostatic Antibiotics Product
Table 87. Mylan Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 88. Mylan Recent Development
Table 89. Sun Pharmaceutical Industries Company Details
Table 90. Sun Pharmaceutical Industries Business Overview
Table 91. Sun Pharmaceutical Industries Bacteriostatic Antibiotics Product
Table 92. Sun Pharmaceutical Industries Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 93. Sun Pharmaceutical Industries Recent Development
Table 94. Hikma Pharmaceuticals Company Details
Table 95. Hikma Pharmaceuticals Business Overview
Table 96. Hikma Pharmaceuticals Bacteriostatic Antibiotics Product
Table 97. Hikma Pharmaceuticals Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 98. Hikma Pharmaceuticals Recent Development
Table 99. Akorn Company Details
Table 100. Akorn Business Overview
Table 101. Akorn Bacteriostatic Antibiotics Product
Table 102. Akorn Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 103. Akorn Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 107. Merck Recent Development
Table 108. Guanhao Biotech Company Details
Table 109. Guanhao Biotech Business Overview
Table 110. Guanhao Biotech Bacteriostatic Antibiotics Product
Table 111. Guanhao Biotech Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 112. Guanhao Biotech Recent Development
Table 113. Lianhuan Pharmaceutical Group Company Details
Table 114. Lianhuan Pharmaceutical Group Business Overview
Table 115. Lianhuan Pharmaceutical Group Bacteriostatic Antibiotics Product
Table 116. Lianhuan Pharmaceutical Group Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 117. Lianhuan Pharmaceutical Group Recent Development
Table 118. Layn Company Details
Table 119. Layn Business Overview
Table 120. Layn Bacteriostatic Antibiotics Product
Table 121. Layn Revenue in Bacteriostatic Antibiotics Business (2016-2021) & (US$ Million)
Table 122. Layn Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bacteriostatic Antibiotics Market Share by Type: 2020 VS 2027
Figure 2. Tetracycline Features
Figure 3. Doxycycline Features
Figure 4. Chloramphenicol Features
Figure 5. Erythromycin Features
Figure 6. Fusidic acid Features
Figure 7. Sulfonamides Features
Figure 8. Trimethoprim Features
Figure 9. Macrolides Features
Figure 10. Lincosamides Features
Figure 11. Other Features
Figure 12. Global Bacteriostatic Antibiotics Market Share by Application: 2020 VS 2027
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Other Case Studies
Figure 16. Bacteriostatic Antibiotics Report Years Considered
Figure 17. Global Bacteriostatic Antibiotics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Bacteriostatic Antibiotics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Bacteriostatic Antibiotics Market Share by Regions: 2020 VS 2027
Figure 20. Global Bacteriostatic Antibiotics Market Share by Regions (2022-2027)
Figure 21. Global Bacteriostatic Antibiotics Market Share by Players in 2020
Figure 22. Global Top Bacteriostatic Antibiotics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacteriostatic Antibiotics as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Bacteriostatic Antibiotics Revenue in 2020
Figure 24. Global Bacteriostatic Antibiotics Revenue Market Share by Type (2016-2021)
Figure 25. Global Bacteriostatic Antibiotics Revenue Market Share by Type (2022-2027)
Figure 26. North America Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Bacteriostatic Antibiotics Market Share by Type (2016-2027)
Figure 28. North America Bacteriostatic Antibiotics Market Share by Application (2016-2027)
Figure 29. North America Bacteriostatic Antibiotics Market Share by Country (2016-2027)
Figure 30. United States Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Bacteriostatic Antibiotics Market Share by Type (2016-2027)
Figure 34. Europe Bacteriostatic Antibiotics Market Share by Application (2016-2027)
Figure 35. Europe Bacteriostatic Antibiotics Market Share by Country (2016-2027)
Figure 36. Germany Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Bacteriostatic Antibiotics Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Bacteriostatic Antibiotics Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Bacteriostatic Antibiotics Market Share by Region (2016-2027)
Figure 46. China Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Bacteriostatic Antibiotics Market Share by Type (2016-2027)
Figure 54. Latin America Bacteriostatic Antibiotics Market Share by Application (2016-2027)
Figure 55. Latin America Bacteriostatic Antibiotics Market Share by Country (2016-2027)
Figure 56. Mexico Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Bacteriostatic Antibiotics Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Bacteriostatic Antibiotics Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Bacteriostatic Antibiotics Market Share by Country (2016-2027)
Figure 62. Turkey Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Bacteriostatic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Tetraphase Pharmaceuticals Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 66. Allergan Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 68. Mylan Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 69. Sun Pharmaceutical Industries Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 70. Hikma Pharmaceuticals Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 71. Akorn Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 72. Merck Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 73. Guanhao Biotech Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 74. Lianhuan Pharmaceutical Group Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 75. Layn Revenue Growth Rate in Bacteriostatic Antibiotics Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

以下、関連資料のご紹介

世界の全身性抗生物質市場規模・現状・予測（2021年-2027年）

Global Systemic Antibiotics Market Size, Status and Forecast 2021-2027
QFJ1-4928 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、全身性抗生物質の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（βラクタム・βラクタマーゼ阻害剤、キノロン、マクロライド、その他）、用途別市場規模（病院、専門クリニック、在宅医療、その他）、主要地域別市...

世界の抗生物質有効成分市場規模・現状・予測（2021年-2027年）

Global Antibiotics Active Pharmaceutical Ingredient Market Size, Status and Forecast 2021-2027
QFJ1-3821 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、抗生物質有効成分の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質）、用途別市場規模（製薬会社、医薬品製造受託機関（CMO）、医薬...

世界の扁桃周囲膿瘍治療市場規模・現状・予測（2021年-2027年）

Global Peritonsillar Abscess Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5940 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、扁桃周囲膿瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、ステロイド薬、鎮痛薬、経口吸引システム、往復手術装置、扁桃摘出装置）、用途別市場規模（病院、外来手術センター、専門クリニック、...

世界の眼瞼炎薬市場規模・現状・予測（2021年-2027年）

Global Blepharitis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5625 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、眼瞼炎薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ステロイド、抗生物質）、用途別市場規模（単剤療法、併用薬物療法）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の気管支拡張症薬市場規模・現状・予測（2021年-2027年）

Global Bronchiectasis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5637 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、気管支拡張症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、去痰薬、その他）、用途別市場規模（病院、研究所、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の牛乳房炎市場規模・現状・予測（2021年-2027年）

Global Bovine Mastitis Market Size, Status and Forecast 2021-2027
QFJ1-5633 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、牛乳房炎の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、その他）、用途別市場規模（授乳期、乾乳期）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中...

世界の鼻ポリープ治療薬市場規模・現状・予測（2021年-2027年）

Global Nasal Polyps Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4549 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、鼻ポリープ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年）

Global Bronchiectasis Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-3943 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、気管支拡張症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、去痰薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の抗潰瘍薬市場規模・現状・予測（2021年-2027年）

Global Antiulcerant Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5591 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、抗潰瘍薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロトンポンプ阻害剤、H2受容体拮抗薬、胃粘膜保護薬、抗生物質、制酸剤、プロスタグランジン作動薬）、用途別市場規模（口内潰瘍、胃潰瘍、下腿潰瘍、...

世界の咽後膿瘍治療市場規模・現状・予測（2021年-2027年）

Global Retropharyngeal Abscess Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4830 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、咽後膿瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、鎮痛剤、外科的ドレナージ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の全身性抗生物質市場規模・現状・予測（2021年-2027年） It refers to a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants that have anti-pathogens or other activities during their life, and can interfere with the development of other living cells. substance. Market Analysis an…
アミノグリコシド系抗生物質のグローバル市場2021 Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics. The classifi…
世界の抗生物質有効成分市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Antibiotics Active Pharmaceutical Ingredient Market The global Antibiotics Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy i…
動物用抗生物質＆抗菌薬のグローバル市場調査 2019年 The global Animal Antibiotics and Antimicrobials market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Animal Antibiotics and Antimicrobials volume and value at global level, regional level and company le…
抗生物質＆抗真菌薬のグローバル市場調査 2019年 The global Antibiotics and Antimycotics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Antibiotics and Antimycotics volume and value at global level, regional level and company level. From a global…